[Lymecycline in the treatment of subacute sinusitis. Clinical study].
After evaluation of the clinical efficacy and the tolerance of lymecycline 2 x 300 mg/day in patients with subacute sinusitis, we may conclude that lymecycline can be considered a first choice antibioticum in the treatment of acute and subacute sinusitis (Tetralysal).
D000328:Adult; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008194:Lymecycline / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D008443:Maxillary Sinus; D012852:Sinusitis / Q000188:drug therapy*; D013754:Tetracyclines / Q000008:administration & dosage*
D013754:Tetracyclines; D008194:Lymecycline
Lymecycline in de behandeling van subakute sinusitis. Klinische studie.